BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+11.69%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.02B
AUM Growth
+$1.02B
(+3.9%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
51.66%
Holding
52
New
9
Increased
8
Reduced
25
Closed
1
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$36.7M |
| 2 |
Merus
MRUS
|
$34M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$23.8M |
| 4 |
Galmed Pharmaceuticals
GLMD
|
$21M |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$17.9M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$94.4M |
| 2 |
ARQL
Arqule Inc
ARQL
|
$49.7M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$14M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$6.55M |
| 5 |
Arcus Biosciences
RCUS
|
$3.79M |
Sector Composition
| 1 | Healthcare | 83.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zymeworks
ZYME
$1.07B
| $293K | 0.03% |
+19,804
| New | +$293K |
|
|
OREX
52
DELISTED
Orexigen Therapeutics, Inc.
OREX
| – | – |
-534,900
| Closed | -$108K |
|